Viewing Study NCT00862134


Ignite Creation Date: 2025-12-25 @ 2:30 AM
Ignite Modification Date: 2026-01-07 @ 11:28 AM
Study NCT ID: NCT00862134
Status: TERMINATED
Last Update Posted: 2013-01-10
First Post: 2009-03-12
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Randomized, Multi-center, Open-label, Study of PR104 Versus PR104/Docetaxel in Non-Small Cell Lung Cancer (NSCLC)
Sponsor: Proacta, Incorporated
Organization: